Dr. Ayse Meric Ovacik has a Ph.D. in Chemical and Biochemical Engineering from Rutgers. She has pursued a postdoctoral fellowship in pharmaceutical science at SUNY Buffalo. Meric has 9+ years industry experience in large molecule drug development from early discovery, including target validation to translational strategies for FiH study trial designs. Her research interests are cancer immunotherapy, bispecific antibodies, and large molecule PK/PD.
Genentech
South San Francisco, California, USA